[New trends in neoadjuvant chemoradiotherapy for locally-advanced esophageal cancer: esophagectomy--is it necessary?].
In responders to neoadjuvant chemoradiotherapy for locally-advanced esophageal cancer, there was no significant difference in the long-term outcome between patients who underwent esophagectomy and those who did not. Esophagectomy might be unnecessary for patients who achieve a complete response with chemoradiotherapy for an esophageal cancer, in cases when salvage surgery is considered in order to treat any future recurrence.
Fujita
H
H
Dept. of Surgery, Kurume University School of Medicine, Fukuoka, Japan.
Sueyoshi
S
S
Tanaka
T
T
Toh
U
U
Mine
T
T
Sasahara
H
H
Shirouzu
K
K
Yamana
H
H
Toda
Y
Y
Hayabuchi
N
N
D002294:Carcinoma, Squamous Cell / Q000188:drug therapy / Q000532:radiotherapy / Q000556:secondary / Q000601:surgery*; D017024:Chemotherapy, Adjuvant / Q000639:trends; D004938:Esophageal Neoplasms / Q000188:drug therapy / Q000473:pathology / Q000532:radiotherapy / Q000601:surgery*; D016629:Esophagectomy; D005260:Female; D006801:Humans; D008207:Lymphatic Metastasis; D008297:Male; D008875:Middle Aged; D020360:Neoadjuvant Therapy / Q000639:trends; D018714:Radiotherapy, Adjuvant / Q000639:trends; D015996:Survival Rate